Cargando…
An Update on Glioblastoma Biology, Genetics, and Current Therapies: Novel Inhibitors of the G Protein-Coupled Receptor CCR5
The mechanisms governing therapeutic resistance of the most aggressive and lethal primary brain tumor in adults, glioblastoma, have increasingly focused on tumor stem cells. These cells, protected by the periarteriolar hypoxic GSC niche, contribute to the poor efficacy of standard of care treatment...
Autores principales: | Lah Turnšek, Tamara, Jiao, Xuanmao, Novak, Metka, Jammula, Sriharsha, Cicero, Gina, Ashton, Anthony W., Joyce, David, Pestell, Richard G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123168/ https://www.ncbi.nlm.nih.gov/pubmed/33923334 http://dx.doi.org/10.3390/ijms22094464 |
Ejemplares similares
-
Cytokine CCL5 and Receptor CCR5 Axis in Glioblastoma Multiforme
por: Kranjc, Miha Koprivnikar, et al.
Publicado: (2019) -
CCR5-Mediated Signaling is Involved in Invasion of Glioblastoma Cells in Its Microenvironment
por: Novak, Metka, et al.
Publicado: (2020) -
OMRT-11. The effect of microenvironment on glioblastoma stem cells therapeutic resistance
por: Turnsek, Tamara Lah, et al.
Publicado: (2021) -
The Role and Therapeutic Targeting of CCR5 in Breast Cancer
por: Hamid, Rasha, et al.
Publicado: (2023) -
TRIM28 Selective Nanobody Reduces Glioblastoma Stem Cell Invasion
por: Porčnik, Andrej, et al.
Publicado: (2021)